Parenteral Nutrition Assessment and Plan for Severe Acute Pancreatitis with Ileus
This patient requires parenteral nutrition (PN) because enteral nutrition is contraindicated due to prolonged ileus, and he has been NPO for 5 days with severe acute pancreatitis. 1, 2
Indication for PN
- PN is indicated when enteral nutrition (EN) is impossible or contraindicated, which applies here due to prolonged ileus and inability to tolerate enteral feeding 3, 1, 2
- The patient has been NPO for 5 days, meeting the threshold where nutritional support becomes necessary (>5-7 days of starvation) 1, 4
- Severe acute pancreatitis with ileus represents a clear contraindication to EN, making PN the appropriate route 1, 5
- PN does not significantly stimulate pancreatic secretion and has no adverse effect on pancreatic function 1
Energy and Protein Requirements
Target 25-35 kcal/kg/day for energy, which equals approximately 1750-2450 kcal/day for this 70 kg patient 4, 6
- During the acute phase, provide trophic PN at 20-25% of calculated requirements (approximately 440-610 kcal/day initially) to avoid overfeeding during critical illness 5
- Protein requirement: 1.2-1.5 g/kg/day, which equals 84-105 g/day (approximately 10-15% of total calories) 4
- As the acute inflammatory phase resolves and ileus improves, gradually advance toward full caloric goals 5
PN Composition
Standard three-compartment formulation:
- Carbohydrates: 55-60% of total calories, with glucose administration not exceeding 4-5 g/kg/day (maximum 280-350 g/day for this patient) 4
- Lipids: 25-30% of total calories, using less-inflammatory intravenous lipid emulsions 5, 4
- Amino acids: 10-15% of total calories (1.2-1.5 g/kg/day as noted above) 4
- Consider glutamine supplementation in severe progressive pancreatitis, as parenteral immunonutrition with glutamine and omega-3 fatty acids reduces infectious complications (RR 0.59), mortality (RR 0.26), and length of stay (2.93 days shorter) 7, 4
Monitoring Requirements
Critical monitoring parameters to prevent complications:
- Triglyceride levels: Monitor closely due to lipid infusion, especially given baseline triglycerides of 120 mg/dL 1, 4
- Glucose monitoring: Tight glycemic control with baseline glucose 110 mg/dL; expect increased requirements due to stress hyperglycemia 4
- Electrolytes daily: Monitor for refeeding syndrome risk (phosphorus, potassium, magnesium) given 5 days NPO status 5
- Liver enzymes: Baseline normal, but monitor for PN-associated liver dysfunction 3
- Catheter-related infection surveillance: PN in acute pancreatitis carries higher catheter sepsis risk (10.5% vs 1.5% in other conditions) 1
Micronutrient Supplementation
- Standard multivitamin supplementation should be included in the PN formulation 1
- Trace elements (zinc, selenium, copper, chromium, manganese) should be provided 3
- Given albumin 3.2 g/dL and prealbumin 15 mg/dL indicating mild malnutrition, ensure adequate micronutrient repletion 3
Transition Strategy
Plan for transition to enteral nutrition as soon as ileus resolves:
- Attempt EN trial when bowel sounds return and ileus resolves, as EN is superior to PN in severe acute pancreatitis regarding infectious complications and outcomes 3, 1, 2
- Use combination PN + EN during transition period, decreasing PN volume as EN tolerance increases 1
- Nasogastric feeding is equivalent to nasojejunal feeding when EN becomes feasible 8
- Complete transition to EN when patient tolerates 60-70% of requirements enterally 1
Common Pitfalls to Avoid
- Do not overfeed during acute phase: Trophic dosing (20-25% of requirements) is safer than full feeding in early critical illness 5
- Do not use PN if EN is feasible: EN is always preferred when tolerated due to superior outcomes 3, 1, 2
- Do not add prophylactic antibiotics: Not indicated for PN in pancreatitis 9
- Do not delay PN if EN truly contraindicated: Waiting beyond 5-7 days without nutrition in severe disease increases morbidity 1, 4